Paloma Partners’s Tenet Healthcare THC Stock Holding History

Paloma Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-300,000	Closed	-$15.2M	–	1424
2014 Q4	$15.2M	Buy	+300,000	New	+$15.7M	0.65%	27

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Paloma Partners's THC Position: Q4 2024 in Review

Paloma Partners sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 7,170 shares — an estimated $1.19M sold.

Paloma Partners first reported a position in THC in Q2 2013 and held it in 22 quarters. The position peaked at $3.38M in Q2 2015. 577 funds tracked by Wall St. Rank hold THC as of Q4 2024.

Paloma Partners reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 7,170 Tenet Healthcare shares in Q4 2024, an estimated $1.19M.
Paloma Partners first reported a position in Tenet Healthcare in Q2 2013 and held it in 22 quarters.
Paloma Partners's Tenet Healthcare position peaked at $3.38M in Q2 2015.
577 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.